Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MNST vs MRNA✓SelectedUSD · MRNAMNST vs MRNA performance historyLatest closeAs of-1.42%11/16
Stock and ETF performance explorer

MNST vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+219.1%
MRNA return
+878.5%
Excess return
-659.4%
Maximum drawdown
-27.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.4%-3.6%+2.2%-1.3%
7D+0.4%-20.0%+20.3%+0.9%
30D+0.2%-1.3%+1.4%+0.1%
3M-2.2%+240.0%-242.2%-7.6%
6M+5.2%+339.0%-333.8%-2.2%
YTD+19.5%+630.0%-610.5%+8.1%
1Y+28.5%+769.1%-740.6%+15.2%
3Y+66.2%+181.2%-115.0%+54.0%
5Y+98.4%-8.1%+106.5%+89.5%
All+219.1%+878.5%-659.4%+160.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling